Pharmaceutical Technology
SEPTEMBER 23, 2022
Dry eye syndrome (DES) is an indication whose mainstay treatment has been dominated by Allergan’s Restasis (cyclosporine ophthalmic emulsion 0.05%) ever since its launch in 2003 in the US. NOV-03 is also likely to be well-received by physicians and patients due to its favorable clinical and tolerability profile.
Legacy MEDSearch
NOVEMBER 22, 2022
By focusing on a collaborative team approach with physicians and industry partners, ChoiceSpine continues to deliver upon product commitments, maintain cutting-edge research and development, and bring technically superior products to the forefront of the spinal implant industry.
European Pharmaceutical Review
MARCH 11, 2024
As a physician scientist with knowledge and experience in translational medicine and late-stage drug development, Sherene has a proven record in drug development including successful regulatory interactions with US and international agencies. References 1. World Health Organization. The Global Health Observatory. Internet] 2023.
Clarify Health
OCTOBER 3, 2022
Niall is the former Chief Data Officer of the Centers for Medicare & Medicaid (CMS), where he led groundbreaking efforts to release hospital and physician data for research, including the creation of the Virtual Research Data Center (VRDC) and Qualified Entity (QE) programs.
Clarify Health
OCTOBER 3, 2022
Niall is the former Chief Data Officer of the Centers for Medicare & Medicaid (CMS), where he led groundbreaking efforts to release hospital and physician data for research, including the creation of the Virtual Research Data Center (VRDC) and Qualified Entity (QE) programs.
Nixon Gwilt Law
NOVEMBER 10, 2022
And that’s because pharmacy is an incredibly important part of the healthcare ecosystem—for many patients, they see their pharmacist far more often than their primary care physician. Due to the success of the North Dakota Telepharmacy Project, the Board of Pharmacy in North Dakota permanently implemented telepharmacy regulations in 2003.
European Pharmaceutical Review
JULY 20, 2023
Available from: [link] Directive 2002/98/EC of the European Parliament and of the Council of 27 January 2003 setting standards of quality and safety for the collection, testing, processing, storage and distribution of human blood and blood components and amending Directive 2001/83/EC (OJ L 33, 8.2.2003, p.30). Cited 2023Mar].
Expert insights. Personalized for you.
59 
Let's personalize your content